Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Kemper $150 million fixed-rate reset junior subordinated debentures offering
The investment-grade rated debentures are due 2062
Macy’s Retail Holdings $850 million senior notes offering
The high-yield notes are due 2030 and 2032
Roche Holdings $5 billion notes offering
We advised Roche on the Rule 144A / Regulation S offering comprising five tranches of notes
Sumitomo Mitsui Trust Bank $1 billion senior notes offering
We advised Sumitomo Mitsui Trust Bank on the update of its global MTN program and senior notes offering
Toronto-Dominion Bank $4.5 billion notes offering
The investment-grade debt offering consists of four tranches
Weyerhaeuser $900 million notes offering and concurrent cash tender offer
The tender offer was funded with the proceeds of the investment-grade notes offering
SatixFy $813 million combination with Endurance Acquisition
We are advising SatixFy on the transaction
Advance Auto Parts $350 million notes offering
The company issued investment-grade notes due 2032
Valero Energy $1 billion cash tender offer
The company purchased certain debt securities
Valuence Merger Corp. I $200 million IPO
The issuer, a SPAC, offered 20,000,000 units which were listed on Nasdaq